HomepageMedicinePharma Pulse 2/7/25: SCOPE Summit 2025 Coverage, Genetic Sensitivity to Stress Possibly Links to Lung Cancer & more Medicine Pharma Pulse 2/7/25: SCOPE Summit 2025 Coverage, Genetic Sensitivity to Stress Possibly Links to Lung Cancer & more admin Posted on February 10, 2025 The latest news for pharma industry insiders. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostSignature Global Q3 results: Signature Global trims net debt 29% to ₹720 crore on strong sales, internal cash flows Next PostVice premier stresses all-out rescue efforts in SW China's landslide You Might Also Like Medicine An Enterprise-Wide Approach to Customer Intelligence admin January 2, 2024 Medicine FDA Grants Accelerated Approval to Pfizer’s Braftovi Combination for Metastatic Colorectal Cancer admin December 24, 2024 Medicine FDA Approves Keytruda Plus Pemetrexed, Platinum Chemotherapy for Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma admin September 19, 2024 Medicine Jazz Pharmaceuticals Completes Biologics License Application for Zanidatamab for HER2-Positive Metastatic Biliary Tract Cancer admin April 2, 2024
Medicine FDA Grants Accelerated Approval to Pfizer’s Braftovi Combination for Metastatic Colorectal Cancer admin December 24, 2024
Medicine FDA Approves Keytruda Plus Pemetrexed, Platinum Chemotherapy for Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma admin September 19, 2024
Medicine Jazz Pharmaceuticals Completes Biologics License Application for Zanidatamab for HER2-Positive Metastatic Biliary Tract Cancer admin April 2, 2024